Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,650 | 12,490 | 17,470 | 24,170 | 6,250 |
| Marketable Securities | 9,010 | 69,040 | 39,280 | 35,090 | 21,340 |
| Receivables | 26,850 | 74,840 | 19,500 | 19,320 | 19,080 |
| Inventories | 10,340 | 16,330 | 6,330 | 5,220 | 4,340 |
| Other current assets | 2,290 | 3,730 | 2,400 | 2,630 | 2,100 |
| TOTAL | $74,140 | $176,430 | $84,980 | $86,430 | $53,110 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 86,890 | 132,840 | 20,500 | 20,500 | 18,690 |
| TOTAL | $86,890 | $132,840 | $20,500 | $20,500 | $18,690 |
| Total Assets | $174,980 | $330,960 | $117,110 | $118,210 | $82,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,040 | 3,200 | 2,160 | 1,860 | 1,560 |
| Accounts payable and accrued liabilities | 27,390 | 42,550 | 17,210 | 16,100 | 16,240 |
| Other current liabilities | 0 | 39,690 | 0 | 0 | 0 |
| TOTAL | $31,720 | $132,230 | $19,790 | $18,160 | $17,880 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,440 | 9,960 | 7,680 | 7,750 | 6,430 |
| Other Non-Current Liabilities | 55,170 | 30,710 | 14,960 | 13,260 | 12,040 |
| TOTAL | $69,350 | $88,380 | $22,640 | $21,010 | $18,470 |
| Total Liabilities | $101,090 | $220,630 | $42,450 | $39,170 | $36,370 |
| Shareholders' Equity | |||||
| Common Shares | 101,630 | 153,570 | 97,360 | 97,940 | 61,170 |
| Retained earnings | -32,900 | -44,860 | -23,580 | -19,690 | -15,500 |
| Other shareholders' equity | 400 | 770 | 330 | 240 | 80 |
| TOTAL | $73,880 | $110,330 | $74,650 | $79,030 | $45,750 |
| Total Liabilities And Equity | $174,970 | $330,960 | $117,100 | $118,200 | $82,120 |